Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multi-centric Castleman's Disease × Valganciclovir × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Sarcoma 1

Conditions

Sarcoma, Kaposi 2 Acquired Immunodeficiency Syndrome 2 Multi-centric Castleman's Disease 1 Immune Reconstitution Inflammatory Syndrome 1 Castleman Disease 1

Interventions

tocilizumab 1 pomalidomide 1 liposomal doxorubicin 1 Zidovudine 1 Valganciclovir 1 Polymerase Chain Reaction 1 Histological Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01441063 2020-10-27

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

8 enrolled 18 charts

LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Castleman Disease, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡